Drugs / F598
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03222401 | Nov 2017 → Mar 2018 | gonorrhea | Alopexx Pharmaceuticals, LLC | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | F598 | “F598” NCT03222401 ↗ |